company background image
CAU

Cronos AustraliaASX:CAU Stock Report

Market Cap

AU$22.5m

7D

6.1%

1Y

101.1%

Updated

25 Oct, 2021

Data

Company Financials
CAU fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

CAU Overview

Cronos Australia Limited operates as a medicinal cannabis company in Australia and Asia.

Price History & Performance

Summary of all time highs, changes and price drops for Cronos Australia
Historical stock prices
Current Share PriceAU$0.17
52 Week HighAU$0.076
52 Week LowAU$0.20
Beta0
1 Month Change12.90%
3 Month Change45.83%
1 Year Change101.15%
3 Year Changen/a
5 Year Changen/a
Change since IPO-48.53%

Recent News & Updates

Shareholder Returns

CAUAU HealthcareAU Market
7D6.1%2.1%0.6%
1Y101.1%14.2%21.3%

Return vs Industry: CAU exceeded the Australian Healthcare industry which returned 14.2% over the past year.

Return vs Market: CAU exceeded the Australian Market which returned 21.3% over the past year.

Price Volatility

Is CAU's price volatile compared to industry and market?
CAU volatility
CAU Beta0
Industry Beta0.61
Market Beta1

Stable Share Price: CAU is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: CAU's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2018n/aRodney Cockshttps://www.cronosaustralia.com

Cronos Australia Limited operates as a medicinal cannabis company in Australia and Asia. It operates through three segments: Medical, Clinics, and Consumer. The company distributes PEACE NATURALS brand medicinal cannabis products; develops and sells medicinal cannabis products under the Adaya brand; and operates medicinal cannabis clinics.

Cronos Australia Fundamentals Summary

How do Cronos Australia's earnings and revenue compare to its market cap?
CAU fundamental statistics
Market CapAU$22.53m
Earnings (TTM)-AU$4.05m
Revenue (TTM)AU$1.69m

13.3x

P/S Ratio

-5.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CAU income statement (TTM)
RevenueAU$1.69m
Cost of RevenueAU$819.91k
Gross ProfitAU$872.93k
ExpensesAU$4.92m
Earnings-AU$4.05m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.031
Gross Margin51.57%
Net Profit Margin-239.20%
Debt/Equity Ratio21.8%

How did CAU perform over the long term?

See historical performance and comparison

Valuation

Is Cronos Australia undervalued compared to its fair value and its price relative to the market?

2.42x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate CAU's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate CAU's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CAU is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.

PE vs Market: CAU is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CAU's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CAU is overvalued based on its PB Ratio (2.4x) compared to the AU Healthcare industry average (2.1x).


Future Growth

How is Cronos Australia forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

1.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cronos Australia has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Cronos Australia performed over the past 5 years?

-38.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CAU is currently unprofitable.

Growing Profit Margin: CAU is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CAU is unprofitable, and losses have increased over the past 5 years at a rate of 38.9% per year.

Accelerating Growth: Unable to compare CAU's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CAU is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (61.3%).


Return on Equity

High ROE: CAU has a negative Return on Equity (-45.6%), as it is currently unprofitable.


Financial Health

How is Cronos Australia's financial position?


Financial Position Analysis

Short Term Liabilities: CAU's short term assets (A$11.8M) exceed its short term liabilities (A$3.2M).

Long Term Liabilities: CAU's short term assets (A$11.8M) exceed its long term liabilities (A$253.7K).


Debt to Equity History and Analysis

Debt Level: CAU's debt to equity ratio (21.8%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if CAU's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CAU has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CAU has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 45.3% each year.


Dividend

What is Cronos Australia current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CAU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CAU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CAU's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CAU's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CAU's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average board tenure


CEO

Rodney Cocks

3.08yrs

Tenure

AU$420,540

Compensation

Mr. Rodney Damon Cocks, CSM, is an Executive Director and Chief Executive Officer at Cronos Australia Limited since September 27, 2018. Mr. Cocks is a Director of NewSouthern Capital, a private equity firm...


CEO Compensation Analysis

Compensation vs Market: Rodney's total compensation ($USD315.25K) is about average for companies of similar size in the Australian market ($USD302.38K).

Compensation vs Earnings: Rodney's compensation has increased whilst the company is unprofitable.


Board Members

Experienced Board: CAU's board of directors are considered experienced (3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cronos Australia Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Cronos Australia Limited
  • Ticker: CAU
  • Exchange: ASX
  • Founded: 2018
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: AU$22.531m
  • Shares outstanding: 128.75m
  • Website: https://www.cronosaustralia.com

Location

  • Cronos Australia Limited
  • 299 Toorak Road
  • Suite 8
  • South Yarra
  • Victoria
  • 3141
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/25 16:59
End of Day Share Price2021/10/25 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.